Our partner Daniel Scherman, CNRS, is the laureate 2017 of the Emilia Valori prize of applied sciences (chemistry, biology and medicine and their application)

Institut de France – Académie des sciences: “The Emilia Valori prize for applied sciences 2017 was awarded to Daniel Scherman, director of the CNRS, Dep. of chemical and biological techniques for health of the pharmaceutical faculty, Paris.

His principal field of interest is the gene therapy using synthetic oligonucleotides or bacterial plasmids. He discovered especially powerful techniques for the delivery of these vectors by chemical methods and, particularly, by electroporation, enabling a 1000-fold increase in gene transfer efficacy. It is this key discovery that allowed the development of important vaccinations and treatments of diseases like age-related macular degeneration.”

http://www.academie-sciences.fr/fr/Laureats/laureat-2017-du-prix-emilia-valori.html

11. January 2018
Categories: Target AMD